ICD-10-CM Billable Code

H43.821

Vitreomacular adhesion, right eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Vitreomacular adhesion (VMA) occurs when the vitreous gel inside the eye does not separate properly from the central retina, known as the macula. This condition affects one eye, in this case, the right eye, and can influence vision quality. While some individuals experience no symptoms, others may develop visual disturbances that warrant medical attention to prevent potential complications. Understanding this condition can help patients grasp its nature, causes, symptoms, and potential management options.

Causes & Symptoms

Clinical Causes: Aging process leading to weakening of the vitreous gel Changes in the vitreous that cause it to adhere abnormally to the macula Previous retinal or eye surgeries that may alter vitreous structure Certain eye conditions, such as diabetic retinopathy or macular holes, that influence vitreoretinal interface dynamics Genetic factors that may predispose neuroretinal adhesion anomalies

Key Symptoms: Mild visual disturbances or blurriness in the right eye Perception of floaters or spots drifting through vision Flashes of light, especially in the peripheral vision Distorted vision, where straight lines appear bent or wavy In some cases, no noticeable symptoms, especially in early stages

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a comprehensive eye examination, including vitally important imaging techniques like optical coherence tomography (OCT). OCT provides detailed cross-sectional images of the retina, helping to visualize the adhesion and assess its extent. Fundus photography and clinical observation also contribute to identifying and monitoring the condition. Regular eye exams are crucial for early detection and management, particularly if symptoms develop or worsen.

Treatment Protocols: Treatment approaches depend on the severity of symptoms and the potential for progression. Many cases of vitreomacular adhesion remain stable without intervention, especially if no vision impairment occurs. When symptoms or risks escalate, options include: - **Observation:** Regular monitoring for changes in the adhesion or vision. - **OCT-guided follow-up:** To assess progression or resolution. - **Surgical interventions:** Such as vitrectomy, where the vitreous gel is removed to release the adhesion; this is typically considered if significant visual impairment or macular holes develop. - **Pharmacologic therapies:** Recent advancements explore enzyme injections to induce vitreous separation, though these are still under clinical evaluation. Patients should consult with specialized ophthalmologists to determine the most suitable management plan based on individual circumstances. Ongoing research seeks less invasive and more effective treatments for vitreomacular adhesion.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H43.821 a billable ICD-10 code?
Yes, H43.821 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H43.821?
Clinical documentation must specify the nature of Vitreomacular adhesion, right eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference